Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) × Glutamyl Aminopeptidase × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Ovarian Neoplasms 1 Neoplasms 1 Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) 1 Liver Neoplasms 1 Gastrointestinal Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

apalutamide 1 Radiotherapy 1 Glutamyl Aminopeptidase 1 Androgen Antagonists 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05649943 2025-09-03

APPROACH

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase NA Recruiting

Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡